2 ASX 200 shares to buy for growth

There are a few S&P/ASX 200 Index (ASX:XJO) shares that are generating high levels of growth right now, including Bapcor Ltd (ASX:BAP).
The post 2 ASX 200 shares to buy for growth appeared first on The Motley Fool Australia. –

arrow exploding over rising finance chart

There are a few S&P/ASX 200 Index (ASX: XJO) shares that are delivering elevated levels of growth at the moment.

COVID-19 has caused flow-on effects to different industries and companies. For some, like travel, it has made it difficult to make any profit at all. For others, there is a lot of growth happening:

Bapcor Ltd (ASX: BAP)

Bapcor describes itself as Asia Pacific’s leading provider of vehicle parts, accessories, equipment, services and solutions, with a network of over 1,100 locations across Australia and New Zealand.

The company had been guiding that the FY21 half-year result would be strong. It was.

Revenue for the six months to 31 December 2020 was up 25.8% to $883.6 million. Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) grew by 36.5% to $145.6 million, underlying EBIT went up 45% to $106.8 million and underlying net profit after tax (NPAT) rose by 54% to $70.2.

Statutory earnings per share (EPS) rose 25.3% to 19.9 cents, allowing the board to increase the interim dividend by 12.5% to 9 cents.

Bapcor said that its trade segment, including Burson, delivered revenue growth of 12.3% and it added another 9 stores during the period.

The retail segment, which includes Autobarn, saw revenue growth of 44% and EBITDA growth of 55.8%.

The ASX 200 share also said that significant progress has been made in its investments for long-term growth. The new distribution warehouse in Melbourne is nearing completion and a new e-commerce platform will soon be launched.

It said that performance in the first month of the second half of FY21 has been at similar levels as the first six months of the year.

Sonic Healthcare Ltd (ASX: SHL)

Sonic is one of the world’s largest pathology businesses with operations in Australia, North America and Europe.

The healthcare ASX 200 share announced its FY21 half-year result a couple of days ago which showed revenue growth of 33% to $4.4 billion.

There has been a significant revenue and earnings contribution from COVID-19 testing, leveraging existing Sonic infrastructure. More than 18 million COVID-19 PCR tests have been performed to date in approximately 60 Sonic laboratories around the world.

The global base business revenue (excluding COVID-19 testing) was down 1% in the first half, but it was significantly less impacted than in the first few month of the pandemic.

Sonic said it managed to grow its profit margins in both its laboratory and imaging operations.

Half-year EBITDA grew by 89% to $1.3 billion and net profit rose by 166% to $678 million. It was this strength that allowed the board to continue the progressive dividend policy, increasing the dividend by 6% to 36 cents.

For the rest of FY21, it’s expecting continuing high levels of COVID-19 testing. It’s looking at growth opportunities globally – Sonic is currently bidding on “significant” opportunities in Australia, the UK, the USA and Canada.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bapcor. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 ASX 200 shares to buy for growth appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!